Ana Mirco

4CPS-160 Lokelma in heart failure patients: safety profile and tolerability –a real-world retrospective cohort study

Marina Lobo Alves, R Andrade, J Salvado, Cristhieni Rodrigues et autres

Background and Importance Managing hyperkalaemia in heart failure (HF) patients remains a clinical challenge, often limiting the use of renin-angiotensin-aldosterone system inhibitors (RAASi), essential for optimising HF therapy. Hospital pharmacists play a crucial role in clinical outcomes and drug monitoring. Lokelma (sodium …

pt (code pays fourni par la source)

Pharmaceutical Teleconsultation for Monitoring Brand Conversion between Tacrolimus Formulations in Kidney Transplant Recipients

Daniela Nepomuceno Rodrigues, Maria Amélia Carneiro, Sara Nery Lopes, Marina Lobo Alves et autres

Del 21 al 23 de Octubre. 71 Congreso Nacional de la Sociedad Española de Farmacia Hospitalaria(SEFH). Participa en el evento científico por excelencia en el marco de la Farmacia Hospitalaria en España.

Sustained Impact of Daily Kaizen Meetings in Hospital Pharmacy: A 5-Year Experience

Margarida Nascimento Pereira, Marina Lobo Alves, Ana Mirco

Del 21 al 23 de Octubre. 71 Congreso Nacional de la Sociedad Española de Farmacia Hospitalaria(SEFH). Participa en el evento científico por excelencia en el marco de la Farmacia Hospitalaria en España.

Age and Clinical Outcomes of Immune Checkpoint Inhibitor Toxicities in Portugal: A Decade of Pharmacovigilance

Tiago Pina-Cabral, José Pereira, João Paulo-Fernandes, Márcia Silva et autres

Background: Real-world safety profiles of immune checkpoint inhibitors (ICIs) in older adults remain insufficiently characterized. Although ICIs are widely used across tumor types, older patients, particularly those with frailty, multimorbidity, or polypharmacy, are consistently under-represented in clinical trials, limiting the external validity …

pt, be (code pays fourni par la source)

Post-marketing surveillance study on the effectiveness and safety of molnupiravir in high-risk COVID-19 outpatients: a prospective case series study

Renato Ferreira‐da‐Silva, Lurdes Silva, Cristina Santos, Manuela Morato et autres

BACKGROUND: Molnupiravir, approved for treating mild to moderate COVID-19 in adults, aims to reduce hospitalisation and mortality rates. Although it was withdrawn from the market after the present study was conducted, understanding its long-term effects remains pertinent. We aimed to assess the …

pt, us (code pays fourni par la source)

4CPS-150 Global evolution of clinical trials and pharmacy activities developed in a central Portuguese hospital from 2016 to 2023

Marina Lobo Alves, Manuela Falcão, T Laranjeira, Ana Mirco et autres

Background and Importance Without effective treatment, an ageing population, new diseases, and rising antimicrobial resistance pose challenges. Clinical trials (CTs) are essential for proving drug efficacy and safety, facilitating access to innovative therapies, and advancing clinical research in Portugal. Legislation mandates Pharmaceutical …

pt, us (code pays fourni par la source)

Remdesivir and corticosteroids in the treatment of hospitalized COVID-19 patients

Luís Coelho, Fátima Falcão, Pedro Manuel Sarmento Rodrigues Póvoa, Erica Viegas et autres

Coronavirus disease 2019 (COVID-19) is a pandemic infection caused by the newly discovered severe acute respiratory syndrome coronavirus 2. Remdesivir (RDV) and corticosteroids are used mainly in COVID-19 patients with acute respiratory failure. The main objective of the study was to assess …

pt, dk (code pays fourni par la source)

4CPS-205 Pharmacist’s intervention in the therapeutic management of patients with heart failure – an opportunity for improvement

Marina Lobo Alves, Rayza Assis de Andrade, Mariana Solano, Celia Coelho Henriques et autres

Background and Importance Patients with Heart Failure (HF) have high morbidity and mortality, which implies the use of a vast number of drugs. This polymedication is associated with a great potential for drug interactions and lack of adherence to treatment by patients. …

pt (code pays fourni par la source)

Successful Treatment of Sthaphylococcus Peritonitis Using Oral Linezolid Without Catheter Removal in a Peritoneal Dialysis Patient

João Carvão, Patrícia Matias, Ana Mirco, Patrícia Quadros Branco

Peritonitis is one of the main complications of peritoneal dialysis and accounts for considerable mortality and hospitalization. It is usually treated with intraperitoneal antibiotherapy, as it is the best way to achieve high concentrations at the site of infection. We report a …

pt (code pays fourni par la source)

4CPS-003 Outpatient-reported experience in hospital pharmacy ambulatory care during the COVID-19 pandemic

Marina Lobo Alves, Ana Paróla, Alexandra Atalaia, Erica Viegas et autres

Background and importance Measuring health care quality and performance is a major challenge in improving health systems’ efficiency. Patient experience is an important health care quality measure; thus, use of questionnaires reporting patients’ experience and perceptions while receiving care is recommended. The …

pt (code pays fourni par la source)

A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report

Fátima Falcão, Erica Viegas, Inês Carmo, Joana Soares et autres

OBJECTIVES: Since the outbreak of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the pressure to minimise its impact on public health has led to the implementation of different therapeutic strategies, the efficacy of which for the treatment of coronavirus disease 2019 (COVID-19) was …

pt (code pays fourni par la source)

Experience of a Portuguese Center: Effectiveness of Direct-Acting Antiviral Therapy for Hepatitis C

Fátima Falcão, Carla Maria Moura Lopes, Erica Viegas, R Pascual Pérez et autres

INTRODUCTION: In late 2014, Portugal implemented a national program for the treatment of patients with chronic hepatitis C with directacting antiviral agents. This program has made Portugal one of the first European countries to implement a structured measure of treatment to eliminate …

pt (code pays fourni par la source)